Comment on

• Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients.

  Kaufman JS, Reda DJ, Fye CL, Goldfarb DS, Henderson WG, Kleinman JG, Vaamonde CA. Kaufman JS, et al. N Engl J Med. 1998 Aug 27;339(9):578-83. doi: 10.1056/NEJM199808273390902. N Engl J Med. 1998. PMID: 9718376 Clinical Trial.
• The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.

  Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA. Besarab A, et al. N Engl J Med. 1998 Aug 27;339(9):584-90. doi: 10.1056/NEJM199808273390903. N Engl J Med. 1998. PMID: 9718377 Clinical Trial.